Suddenly, the up-and-down IPO market is red hot again.

After five companies went public last week, four more IPOs are scheduled to price this week.

None of them packs quite the same punch as Trulia (NYSE: TRLA), the online residential real estate marketplace that’s up more than 30% since its IPO last Thursday. But there could be some hidden gems in here – especially in light of the strong early returns posted by some of last week’s lesser-known IPOs.

Here are the four IPOs scheduled to hit the market this week, according to the IPO website Renaissance Capital:

  • Grupo Financiero Santander Mexico (BSMX): The second-largest bank in Mexico will begin trading on the New York Stock Exchange. It plans to raise $2.8 billion by offering 235 million shares at a price range of $10.99 to $12.70. Even at the low end of the range, that would make BSMX a large-cap stock right off the bat. That’s not unreasonable: the bank did a hefty $3.2 billion in sales over the past 12 months.
  • GlobeImmune (GBIM): A developer of pancreatic cancer and hepatitis B and C drugs, GlobeImmune plans to open at between $11 and $13 a share. The company has booked $9 million in sales the last 12 months.
  • Qualys (QLYS): A cloud-computing software company, Qualys hopes to raise $91 million in its IPO by offering 7.6 million shares at $11 to $13 a pop. The California-based company will list on the Nasdaq exchange.
  • Summit Midstream Partners (SMLP): Summit is a Texas-based natural gas company that’s hoping to capitalize on the ongoing rally in natural gas prices. The company plans to raise $250 million by offering 12.5 million shares at $19 to $21 per. It will list on the New York Stock Exchange.
Published by Wyatt Investment Research at